Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Occlutech PFO Closure Device: A Long-Term Review
Author(s): Daniela Trabattoni Added: 1 year ago
A single centre, prospective, non-randomised study from DrDaniela Trabattoni (Monzino Cardiology Centre,Milan, IT) following device implantation of the Occlutech PFO Closure device in 442 consecutive patients.The study is particularly interesting due to the scarcity of data available on the long term follow up (over 5 years after) of device implantation. Also, the results are focussed not only… View more

Intervention
Aortic Stenosis and TAVI: New Trials, Devices and Data
Author(s): Roxana Mehran , Martin Swaans , Haim Danenberg , et al Added: 1 year ago
In this video series, first presented at the ESC Congress 2023 held in Amsterdam, Prof Roxana Mehran, Dr Antoinette Neylon, Dr Martin Swaans, Prof Raphael Rosenhek and Prof Haim Danenberg discuss the Expand II TAVR pivotal trial design and the rational for investigating the treatment of moderate aortic stenosis patients with Evolut™ TAVI, provide practical Echo imaging recommendations to improve… View more

Heart Failure

Intervention
AHA 24 Late-Breaking Discussion: The NUDGE-FLU Study
Author(s): Harriette Van Spall , Tor Biering-Sørensen Added: 7 months ago
AHA Conference 2024 — New insights from the NUDGE-FLU Program on electronic nudges to increase influenza vaccination amongst patients with a history of myocardial infarction.Dr Harriette Van Spall (McMaster University, CA) sits down with the principal investigator of the NUDGE-FLU trial, (NCT05542004) Dr Tor Biering-Sørensen, to discuss the latest insights and data.NUDGE-FLU is a prospective,… View more

Prevention & Chronic Conditions
ACC 25: Cardiac Biomarker Analysis from the EARLY TAVR Trial
Author(s): Brian Lindman Added: 3 months ago
ACC 2025 - Primary findings from EARLY-TAVR show the benefit of early TAVR intervention was consistent across biomarker subgroups.Dr Brian Lindman (Vanderbilt University Medical Center, Nashville, US) joins us onsite at ACC 2025 to discuss findings from the primary biomarker analysis from the EARLY TAVR trial (NCT03042104; Edwards Lifesciences). The analysis investigated cardiac biomarkers in… View more

Vascular Disease and Surgery
Maternal Cardiac Function in Pregnancies With Metabolic Disorders
Author(s): Deesha Patel , Makrina D Savvidou Added: 1 year ago

Imaging & Diagnostics

Prevention & Chronic Conditions
Cardiac Involvement Due to COVID-19
Author(s): Valentina O Puntmann , Anastasia Shchendrygina , Carlos Rodriguez Bolanos , et al Added: 1 year ago

Imaging & Diagnostics

COVID-19
Research Area(s) / Expertise: Job title: Head of the Cardiac Department and Electrophysiology Lab
Stylianos Tzeis is the Head of the Cardiac Department and EP Lab in Mitera Hospital, Hygeia Group in Athens, Greece. He is a cardiac electrophysiologist with a clinical and research focus on catheter ablation and cardiac implantable electronic devices. He has authored over 100 papers in peer-reviewed journals. He is a member of the board of the European Heart Rhythm Association and since 2017… View more
Fozia Ahmed
Job title: Consultant Cardiologist (Sub-specialty interests in Heart Failure and Cardiac Devices)
Dr Ahmed is an editorial board member for Cardiac Failure Review and with her permission, she may be contactedhere. Personal History Dr Fozia Zahir Ahmed was born in Manchester, England. She is a consultant cardiologist at the Manchester Heart Centre, part of Manchester Royal Infirmary, where she specialises in heart failure and cardiac devices.1 Academic History Dr Ahmed… View more
Comment on Leadless Pacemakers
Author(s): Zaki Akhtar , Manav Sohal , Mark M Gallagher Added: 1 year ago

Heart Failure

Electrophysiology & Arrhythmia
Job title: Cardiologist/Electrophysiologist